151 related articles for article (PubMed ID: 2971278)
21. [Endometrioid carcinoma of the prostate: a histogenetic dilemma with therapeutic implications].
Angulo Cuesta J; López JI; Unda Urzaiz M; Eizaguirre Zarza B; Flores Corral N
Arch Esp Urol; 1990; 43(9):979-81. PubMed ID: 2151109
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study between acid phosphatases and bone gammagraphy in cancer of the prostate].
González Martín M; Lancina Martín A; Chantada Abal V; Lamas Meilán AC; Miguez Codesido M; Serrano Barrientos J
Actas Urol Esp; 1985; 9(1):83-8. PubMed ID: 4013851
[No Abstract] [Full Text] [Related]
23. Initiation of LHRH monotherapy for prostate cancer.
Milsted RA
Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
[No Abstract] [Full Text] [Related]
24. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Jacobi GH; Wenderoth UK
Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
[No Abstract] [Full Text] [Related]
25. [Therapy of virginal prostatic cancer with cyproterone acetate].
Maier U
Z Urol Nephrol; 1985 Apr; 78(4):181-7. PubMed ID: 3160180
[TBL] [Abstract][Full Text] [Related]
26. Treatment of prostatic carcinoma with cyproterone acetate.
Tveter KJ; Otnes B; Hannestad R
Scand J Urol Nephrol; 1978; 12(2):115-8. PubMed ID: 694435
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of hirsutism with peripherally acting antiandrogens. Experiences with cyproterone acetate].
Vinueza G; Zárate A; Canales ES
Ginecol Obstet Mex; 1980 Nov; 48(289):303-9. PubMed ID: 6454611
[No Abstract] [Full Text] [Related]
28. [Use of cyproterone acetate in the treatment of female acne].
Grio R; Marchino GL; Cellura A; Zaccheo F; Giacardi M; Tumiati L
Minerva Ginecol; 1987 Dec; 39(12):887-9. PubMed ID: 2966904
[No Abstract] [Full Text] [Related]
29. [Therapy of vasomotor syndrome in the treatment of advanced prostatic cancer: apropos of 37 cases].
Ronzoni G; De Giovanni L; Menchinelli P; Meneschincheri M
Arch Ital Urol Androl; 1998 Feb; 70(1):37-40. PubMed ID: 9549167
[TBL] [Abstract][Full Text] [Related]
30. [Antiandrogen treatment with cyproterone acetate in with virilizing symptoms].
Abrahamsson L; Hackl H; Lindström B; Martinik J
Lakartidningen; 1981 Nov; 78(47):4259-61. PubMed ID: 6460145
[No Abstract] [Full Text] [Related]
31. [Impact of specific prostatic antigen on the rationalization of the use of bone gammagraphies in the follow-up of hormone-treated non- metastatic prostatic cancer].
Morote Robles J; Reig Ruiz C; Vila Barja J; López Pacios MA; de Torres Mateos JA; Soler Roselló A
Actas Urol Esp; 1993 May; 17(5):292-4. PubMed ID: 7688176
[TBL] [Abstract][Full Text] [Related]
32. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
Smith RB; Walsh PC; Goodwin WE
J Urol; 1973 Jul; 110(1):106-8. PubMed ID: 4713345
[No Abstract] [Full Text] [Related]
33. [Therapy of prostatic cancer with cyproterone acetate].
Maier U
Wien Klin Wochenschr; 1988 Jan; 100(1):16-9. PubMed ID: 2964127
[TBL] [Abstract][Full Text] [Related]
34. Cyproterone acetate for treatment of hot flashes after orchiectomy.
Moon TD
J Urol; 1985 Jul; 134(1):155-6. PubMed ID: 3159912
[No Abstract] [Full Text] [Related]
35. Cyproterone acetate in the treatment of aggression.
Thibaut F; Colonna L
Am J Psychiatry; 1992 Mar; 149(3):411. PubMed ID: 1531581
[No Abstract] [Full Text] [Related]
36. [A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
Vignini M; Pelfini C; Montanari L
Minerva Ginecol; 1988 Feb; 40(2):125-32. PubMed ID: 2969466
[No Abstract] [Full Text] [Related]
37. [Chronic myeloid leukemia and carcinoma of the prostate].
Papineschi F; Bonini R; Pistolisi D; Spremolla G
Sangre (Barc); 1989 Oct; 34(5):383. PubMed ID: 2533407
[No Abstract] [Full Text] [Related]
38. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
Pedersen IM; Nielsen DR; Larsen J; Starup J
Ugeskr Laeger; 1985 Aug; 147(33):2594-6. PubMed ID: 2933858
[No Abstract] [Full Text] [Related]
39. [Cancers of the prostate and cyproterone acetate. Value of blood testosterone and PSA levels for treatment surveillance].
Aubert J; Dore B; Irani J; Bon D
J Urol (Paris); 1990; 96(8):431-5. PubMed ID: 1707083
[TBL] [Abstract][Full Text] [Related]
40. Cyproteron acetate treatment and sexual dysinhibition.
Grinshpoon A; Levy A; Rapoport A; Rabinowitz S
Med Law; 1991; 10(6):609-13. PubMed ID: 1840410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
